News

The additional indications approved by agency for the oral form of Vasolan will provide a wider range of treatment options for patients who are suffering from tachyarrhythmia. This

Under the terms of the agreement, OneWorld Health, Amyris and sanofi-aventis will work jointly to develop and design pilot and commercial scale manufacturing processes, with the goal of

Data demonstrated that LCP-Tacro has a potential best-in-class profile when compared to the currently marketed twice daily tacrolimus capsule, Prograf. LCP-Tacro also shows higher bioavailability by more than

The trial is a two-part double-blind, placebo-controlled evaluation of single ascending doses, followed by a crossover multi-dose evaluation in healthy human volunteers. In addition to safety, other objectives

Company will not receive any proceeds from the sale. The offer is expected to close on March 5, 2008. The offering is being made through an underwriting syndicate

In this study safety and tolerability of escalating doses of AZX100 will be evaluated in healthy adult male subjects. A placebo control arm is included in this Phase

Under the terms of the agreement, China Sky One Medical’s wholly-owned subsidiary, Harbin Tian Di Ren Medical Science and Technology Company, will acquire 100% of Tianlong’s operations for

The study has included patients with acute symptoms of schizophrenia who were treated either with Fiapta (iloperidone), a novel atypical antipsychotic agent or placebo. Patients were also studied

The approval is based on results from a four-week, multicenter, randomized, double-blind, placebo-controlled study in pediatric patients (10 to 17 years old) with bipolar I disorder that demonstrated